Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://www.sentinelinitiative.org/methods-data-tools/methods/advancing-scalable-natural-language-processing-approaches-unstructured Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data Methods, Data, & Tools
Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-erenumab-use-signal Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/covid-19-hospitalization-and-severe-covid-19-infection-0 COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis Analyses
COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/characterization-covid-19-vaccination-data-sdd-0 Characterization of COVID-19 Vaccination Data in the SDD Methods, Data, & Tools
Characterization of COVID-19 Vaccination Data in the SDD
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/systematic-process-assessing-fitness-purpose-health-outcomes-computable A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Records Data Methods, Data, & Tools
A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Records Data
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/data-driven-automated-classification-algorithms-acute-0 Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to COVID-19 Disease Publications and Presentations
Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to COVID-19 Disease
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/incorporate-range-frequently-used-engineering-features-ehrs-sentinel Incorporate a Range of Frequently Used Engineering Features from EHRs into the Sentinel Common Data Model in the Sentinel EHR and Claims Linked Data Partner Network Methods, Data, & Tools
Incorporate a Range of Frequently Used Engineering Features from EHRs into the Sentinel Common Data Model in the Sentinel EHR and Claims Linked Data Partner Network
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydrochlorothiazide-use-following-labeling-update-include-0 Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis Analyses
Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-0 Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis Analyses
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/evaluate-use-dance-algorithm-find-disconnected-negative-controls-and Evaluate the Use of the DANCE Algorithm to Find Disconnected Negative Controls and Develop a Toolkit Methods, Data, & Tools
Evaluate the Use of the DANCE Algorithm to Find Disconnected Negative Controls and Develop a Toolkit
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods Subset Calibration Methods Methods, Data, & Tools
Subset Calibration Methods
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/comparison-signal-detection-and-evaluation-study-designs-inform Comparison of Signal Detection and Evaluation Study Designs to Inform Development of the Pregnancy Safety Framework Methods, Data, & Tools
Comparison of Signal Detection and Evaluation Study Designs to Inform Development of the Pregnancy Safety Framework
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-syphilis-testing-and-treatment-infants Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-syphilis-testing-and-treatment-pregnant Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis Analyses
Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/covid-19-hospitalization-and-severe-covid-19-infection-1 COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Updated Inverse Probability of Treatment Weighting Analysis Analyses
COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Updated Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/assessing-performance-major-congenital-malformations-composite-outcome Assessing the Performance of Major Congenital Malformations as a Composite Outcome in Signal Detection and Evaluation Methods, Data, & Tools
Assessing the Performance of Major Congenital Malformations as a Composite Outcome in Signal Detection and Evaluation
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/renal-cell-carcinoma-algorithm-defined-risk-renal-cell Renal Cell Carcinoma Algorithm Defined in "Risk of Renal Cell Carcinoma Associated with Canagliflozin Versus Sitagliptin in Type 2 Diabetes: A Clone-Censor-Weight Cohort Study" Methods, Data, & Tools
Renal Cell Carcinoma Algorithm Defined in "Risk of Renal Cell Carcinoma Associated with Canagliflozin Versus Sitagliptin in Type 2 Diabetes: A Clone-Censor-Weight Cohort Study"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-renal-cell-carcinoma-associated-canagliflozin-versus Risk of Renal Cell Carcinoma Associated with Canagliflozin Versus Sitagliptin in Type 2 Diabetes: A Clone-Censor-Weight Cohort Study Analyses
Risk of Renal Cell Carcinoma Associated with Canagliflozin Versus Sitagliptin in Type 2 Diabetes: A Clone-Censor-Weight Cohort Study
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2-0 Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: An Active Comparator Signal Identification Analysis Analyses
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: An Active Comparator Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-prucalopride-and-plecanatide Outcome Monitoring Following Prucalopride and Plecanatide Use: An Active Comparator Signal Identification Analysis with Alternating Exposure-Comparator Roles Analyses
Outcome Monitoring Following Prucalopride and Plecanatide Use: An Active Comparator Signal Identification Analysis with Alternating Exposure-Comparator Roles
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-infliximab-biosimilar-product Outcome Monitoring Following Infliximab Biosimilar Product Use: An Active Comparator Signal Identification Analysis Analyses
Outcome Monitoring Following Infliximab Biosimilar Product Use: An Active Comparator Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/dihydropyrimidine-dehydrogenase-dpyd-gene-variant-testing Dihydropyrimidine Dehydrogenase (DPYD) Gene Variant Testing Rates and Fluoropyrimidine Use Following Pharmacogenetic Testing Among Incident Fluoropyrimidine Users: A Descriptive Analysis Analyses
Dihydropyrimidine Dehydrogenase (DPYD) Gene Variant Testing Rates and Fluoropyrimidine Use Following Pharmacogenetic Testing Among Incident Fluoropyrimidine Users: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/prevalence-cutaneous-lupus-erythematosus-sentinel Prevalence of Cutaneous Lupus Erythematosus in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Prevalence of Cutaneous Lupus Erythematosus in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/cautionary-note-plasmode-simulation-studies-setting-causal-0 A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference Publications and Presentations
A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/mycophenolate-use-during-pregnancy-descriptive-analysis Mycophenolate Use During Pregnancy: A Descriptive Analysis Analyses
Mycophenolate Use During Pregnancy: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/frequency-blood-phosphate-monitoring-following-ferric Frequency of Blood Phosphate Monitoring Following Ferric Carboxymaltose (FCM) Administration in Patients in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Frequency of Blood Phosphate Monitoring Following Ferric Carboxymaltose (FCM) Administration in Patients in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-metformin-patients-polycystic-ovarian Utilization Patterns of Metformin in Patients with Polycystic Ovarian Syndrome: A Descriptive Analysis Analyses
Utilization Patterns of Metformin in Patients with Polycystic Ovarian Syndrome: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-metformin-users-polycystic-ovarian-syndrome Characterization of Metformin Users with Polycystic Ovarian Syndrome: A Descriptive Analysis Analyses
Characterization of Metformin Users with Polycystic Ovarian Syndrome: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2026-ispe-annual-meeting 2026 ISPE Annual Meeting Sentinel Initiative Events
2026 ISPE Annual Meeting
Sentinel Initiative Events
https://www.sentinelinitiative.org/news-events/publications-presentations/tree-based-safety-signal-identification-infliximab Tree-Based Safety Signal Identification for Infliximab Biosimilar vs Reference Products Publications and Presentations
Tree-Based Safety Signal Identification for Infliximab Biosimilar vs Reference Products
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/combining-treatment-propensity-scores-and-clone-censor Combining Treatment Propensity Scores and Clone-Censor-Weighting to Evaluate Treatment Duration in Active Comparator Studies Publications and Presentations
Combining Treatment Propensity Scores and Clone-Censor-Weighting to Evaluate Treatment Duration in Active Comparator Studies
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/evaluating-data-driven-automated-discovery-disconnected Evaluating Data-Driven Automated Discovery of Disconnected Negative Controls Using Plasmode Simulations Publications and Presentations
Evaluating Data-Driven Automated Discovery of Disconnected Negative Controls Using Plasmode Simulations
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/prevalence-cutaneous-lupus-erythematosus-us-populations Prevalence of Cutaneous Lupus Erythematosus in U.S. Populations Using the FDA Sentinel Distributed Database Publications and Presentations
Prevalence of Cutaneous Lupus Erythematosus in U.S. Populations Using the FDA Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/fda-safety-communications-labeling-changes/fda-adds-boxed-warning-labeling-ferric FDA Adds Boxed Warning to Labeling for Ferric Carboxymaltose Injection (Injectafer) to Describe Risk of Low Phosphate Levels Regulatory Impact
FDA Adds Boxed Warning to Labeling for Ferric Carboxymaltose Injection (Injectafer) to Describe Risk of Low Phosphate Levels
Regulatory Impact
https://www.sentinelinitiative.org/news-events/publications-presentations/finding-needles-same-haystack-comparing-designated-medical Finding Needles in the Same Haystack: Comparing Designated Medical Event vs Untargeted Approach in Signal Identification Publications and Presentations
Finding Needles in the Same Haystack: Comparing Designated Medical Event vs Untargeted Approach in Signal Identification
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/descriptive-analysis-weight-loss-medication-use-including A Descriptive Analysis of Weight Loss Medication Use, Including GLP-1 RA Products, and Intentional Self-Harm among Patients with Obesity in FDA's Sentinel Distributed Database Publications and Presentations
A Descriptive Analysis of Weight Loss Medication Use, Including GLP-1 RA Products, and Intentional Self-Harm among Patients with Obesity in FDA's Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/risk-intentional-self-harm-after-glp-1-ra-use-among-patients Risk of Intentional Self-Harm After GLP-1 RA Use Among Patients with Type 2 Diabetes in FDA’s Sentinel Distributed Database Publications and Presentations
Risk of Intentional Self-Harm After GLP-1 RA Use Among Patients with Type 2 Diabetes in FDA’s Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/burden-cutaneous-lupus-erythematosus-commercial-vs-publicly Burden of Cutaneous Lupus Erythematosus in Commercial vs. Publicly Insured Patients in the FDA’s Sentinel Distributed Database Publications and Presentations
Burden of Cutaneous Lupus Erythematosus in Commercial vs. Publicly Insured Patients in the FDA’s Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/cardiac-malformations-algorithm-defined-cardiac Cardiac Malformations Algorithm Defined in "Cardiac Malformations and Oral Clefts Following in Utero Exposure to Cyclobenzaprine: A Propensity Score Stratified Analysis" Methods, Data, & Tools
Cardiac Malformations Algorithm Defined in "Cardiac Malformations and Oral Clefts Following in Utero Exposure to Cyclobenzaprine: A Propensity Score Stratified Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/development-and-evaluation-targeted-outcome-trees-safety Development and Evaluation of Targeted Outcome Trees for Safety Surveillance using Tree-Based Scan Statistics in the Sentinel System Publications and Presentations
Development and Evaluation of Targeted Outcome Trees for Safety Surveillance using Tree-Based Scan Statistics in the Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/oral-clefts-algorithm-defined-cardiac-malformations-and Oral Clefts Algorithm Defined in "Cardiac Malformations and Oral Clefts Following in Utero Exposure to Cyclobenzaprine: A Propensity Score Stratified Analysis" Methods, Data, & Tools
Oral Clefts Algorithm Defined in "Cardiac Malformations and Oral Clefts Following in Utero Exposure to Cyclobenzaprine: A Propensity Score Stratified Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/dihydropyrimidine-dehydrogenase-gene-testing-and Dihydropyrimidine Dehydrogenase Gene Testing and Fluoropyrimidine Treatment in the United States – a Sentinel Distributed Database Study Publications and Presentations
Dihydropyrimidine Dehydrogenase Gene Testing and Fluoropyrimidine Treatment in the United States – a Sentinel Distributed Database Study
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/risk-renal-cell-carcinoma-following-least-180-days-exposure Risk of Renal Cell Carcinoma Following At Least 180 Days of Exposure to Canagliflozin in U.S. Patients with Type 2 Diabetes Mellitus Publications and Presentations
Risk of Renal Cell Carcinoma Following At Least 180 Days of Exposure to Canagliflozin in U.S. Patients with Type 2 Diabetes Mellitus
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiac-malformations-and-oral-clefts-following-utero Cardiac Malformations and Oral Clefts Following in Utero Exposure to Cyclobenzaprine: A Propensity Score Stratified Analysis Analyses
Cardiac Malformations and Oral Clefts Following in Utero Exposure to Cyclobenzaprine: A Propensity Score Stratified Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/mycophenolate-use-during-pregnancy-analysis-sentinel Mycophenolate Use During Pregnancy: An Analysis in the Sentinel Database Publications and Presentations
Mycophenolate Use During Pregnancy: An Analysis in the Sentinel Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/assessing-performance-major-congenital-malformations Assessing the Performance of Major Congenital Malformations as a Composite Outcome in Signal Detection and Evaluation Publications and Presentations
Assessing the Performance of Major Congenital Malformations as a Composite Outcome in Signal Detection and Evaluation
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/injectafer-ferric-carboxymaltose-fcm Injectafer (ferric carboxymaltose, FCM) & Serum Phosphate Testing Studies
Injectafer (ferric carboxymaltose, FCM) & Serum Phosphate Testing
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/prenatal-care-and-congenital-syphilis-united-states Prenatal Care and Congenital Syphilis in the United States: Characterizing Screening and Treatment Publications and Presentations
Prenatal Care and Congenital Syphilis in the United States: Characterizing Screening and Treatment
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/aimovig-erenumab-0 Aimovig (Erenumab) & Signal Identification Studies
Aimovig (Erenumab) & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/cutaneous-lupus-erythematosus Cutaneous Lupus Erythematosus & Prevalence Studies
Cutaneous Lupus Erythematosus & Prevalence
Studies
https://www.sentinelinitiative.org/studies/drugs/fluoropyrimidine Fluoropyrimidines & Dihydropyrimidine Dehydrogenase Testing Studies
Fluoropyrimidines & Dihydropyrimidine Dehydrogenase Testing
Studies
https://www.sentinelinitiative.org/studies/drugs/glucagon-peptide-1-receptor-agonists Glucagon-Like Peptide-1 Receptor Agonists & Intentional Self-Harm Studies
Glucagon-Like Peptide-1 Receptor Agonists & Intentional Self-Harm
Studies
https://www.sentinelinitiative.org/studies/drugs/mycophenolate-mofetil-mycophenolic-acid Mycophenolate & Use in Pregnancy Studies
Mycophenolate & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/studies/drugs/semaglutide-injectables Semaglutide Injectables & Signal Identification Studies
Semaglutide Injectables & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/hydrochlorothiazide-1 Hydrochlorothiazide & Utilization Studies
Hydrochlorothiazide & Utilization
Studies
https://www.sentinelinitiative.org/studies/drugs/motegrity-prucalopride Motegrity (Prucalopride) & Signal Identification Studies
Motegrity (Prucalopride) & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/trulance-plecanatide Trulance (Plecanatide) & Signal Identification Studies
Trulance (Plecanatide) & Signal Identification
Studies
https://www.sentinelinitiative.org/methods-data-tools/methods/computable-phenotyping-and-validation-studies-venous-thromboembolism-and Computable Phenotyping and Validation Studies: Venous Thromboembolism and Encapsulated Bacterial Infection Methods, Data, & Tools
Computable Phenotyping and Validation Studies: Venous Thromboembolism and Encapsulated Bacterial Infection
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/infliximab-biosimilars Infliximab Biosimilars & Signal Identification Studies
Infliximab Biosimilars & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-cardiac-malformations-and-oral-clefts-infants-following Risk of Cardiac Malformations and Oral Clefts in Infants Following in Utero Exposure to Cyclobenzaprine: A Sensitivity Analysis Analyses
Risk of Cardiac Malformations and Oral Clefts in Infants Following in Utero Exposure to Cyclobenzaprine: A Sensitivity Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/cyclobenzaprine Cyclobenzaprine & Cardiac Malformations and Oral Clefts Studies
Cyclobenzaprine & Cardiac Malformations and Oral Clefts
Studies
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/cardiac-malformations-algorithm-defined-risk-cardiac Cardiac Malformations Algorithm Defined in "Risk of Cardiac Malformations and Oral Clefts in Infants Following in Utero Exposure to Cyclobenzaprine: A Sensitivity Analysis" Methods, Data, & Tools
Cardiac Malformations Algorithm Defined in "Risk of Cardiac Malformations and Oral Clefts in Infants Following in Utero Exposure to Cyclobenzaprine: A Sensitivity Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/oral-clefts-algorithm-defined-risk-cardiac Oral Clefts Algorithm Defined in "Risk of Cardiac Malformations and Oral Clefts in Infants Following in Utero Exposure to Cyclobenzaprine: A Sensitivity Analysis" Methods, Data, & Tools
Oral Clefts Algorithm Defined in "Risk of Cardiac Malformations and Oral Clefts in Infants Following in Utero Exposure to Cyclobenzaprine: A Sensitivity Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/proton-pump-inhibitors Proton Pump Inhibitors & COVID-19 Hospitalization and Severe COVID-19 Studies
Proton Pump Inhibitors & COVID-19 Hospitalization and Severe COVID-19
Studies
https://www.sentinelinitiative.org/studies/drugs/long-acting-injectable-antipsychotics Long-Acting Injectable Antipsychotics & Mortality Studies
Long-Acting Injectable Antipsychotics & Mortality
Studies